A randomized, double-blind, placebo-controlled, ascending, single-dose study of a human monoclonal anti-FGF23 antibody (KRN23) in X-linked hypophosphatemia
Bone Abstracts(2014)
摘要
Searchable abstracts of presentations at key conferences on calcified tissues ISSN 2052-1219 (online)
更多查看译文
关键词
antibody,double-blind,placebo-controlled,single-dose,anti-fgf,x-linked
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要